<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 11 Apr 2026 23:16:27 -0400--><rss version="2.0">
    <channel>
        <title>TC BioPharm Limited (TCBP) SEC Filings</title>
        <link>https://ir.tcbiopharm.com/sec-filings/annual-reports/rss</link>
        <description>TC BioPharm Limited (TCBP) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/tcbiopharm/files/theme/images/logo-sm.png</url>
                <title>TC BioPharm Limited Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[7 Related Documents: 20-F, EX-12.1, EX-12.2, EX-13.1, EX-16.1, EX-19.1, EX-97.1]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001641172-25-009445/0001641172-25-009445.pdf</link>
                <pubDate>Fri, 09 May 25 16:08:05 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001641172-25-009445/0001641172-25-009445.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 20-F - Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F]]></title>
                <description><![CDATA[NT 20-F]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001641172-25-007678/0001641172-25-007678.pdf</link>
                <pubDate>Wed, 30 Apr 25 16:00:27 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001641172-25-007678/0001641172-25-007678.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K/A, EX-31.1, EX-31.2, EX-32.1, EX-32.2, EX-10.17, EX-10.18]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-24-017053/0001493152-24-017053.pdf</link>
                <pubDate>Mon, 29 Apr 24 17:25:37 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-24-017053/0001493152-24-017053.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-K, EX-31.1, EX-31.2, EX-32.1, EX-32.2, EX-97.1]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-24-012486/0001493152-24-012486.pdf</link>
                <pubDate>Mon, 01 Apr 24 17:18:31 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-24-012486/0001493152-24-012486.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 20-F, EX-4.16, EX-12.1, EX-12.2, EX-13.1]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-23-014970/0001493152-23-014970.pdf</link>
                <pubDate>Mon, 01 May 23 16:23:00 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-23-014970/0001493152-23-014970.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 20-F, EX-4.10, EX-4.11, EX-12.1, EX-12.2, EX-13.1]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-22-013312/0001493152-22-013312.pdf</link>
                <pubDate>Fri, 13 May 22 15:57:59 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-22-013312/0001493152-22-013312.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 20-F - Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F]]></title>
                <description><![CDATA[NT 20-F]]></description>
                <link>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-22-011577/0001493152-22-011577.pdf</link>
                <pubDate>Fri, 29 Apr 22 16:44:57 -0400</pubDate>
                <guid>https://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001493152-22-011577/0001493152-22-011577.pdf</guid>
                                                                            </item>
            </channel>
</rss>